Search Results

There are 28604 results for: content related to: Phase I study of highly selective inhibitor of VEGFR tyrosine kinase, tivozanib, in J apanese patients with solid tumors

  1. Effects of ketoconazole or rifampin on the pharmacokinetics of tivozanib hydrochloride, a vascular endothelial growth factor receptor tyrosine kinase inhibitor

    Clinical Pharmacology in Drug Development

    Volume 4, Issue 2, March/April 2015, Pages: 137–142, Monette M. Cotreau, Nicholas M. Siebers, James Miller, Andrew L. Strahs and William Slichenmyer

    Version of Record online : 1 OCT 2014, DOI: 10.1002/cpdd.145

  2. Absorption, Metabolism, and Excretion of [14C]-Tivozanib, a Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor, in Healthy Male Participants: A Phase I, Open-Label, Mass-Balance Study

    Clinical Pharmacology in Drug Development

    Volume 1, Issue 3, July 2012, Pages: 102–109, Monette M. Cotreau, Christine L. Hale, Lindsey Jacobson, Claudine S. Oelke, Andrew L. Strahs, Robert G. Kochan, Madhu Sanga, William Slichenmyer and Dennis L. Vargo

    Version of Record online : 10 JAN 2013, DOI: 10.1177/2160763X12447303

  3. The effect of food on the pharmacokinetics of tivozanib hydrochloride

    Clinical Pharmacology in Drug Development

    Volume 3, Issue 2, March/April 2014, Pages: 158–162, Monette M. Cotreau, Lisa Massmanian, Andrew L. Strahs, William Slichenmyer and Dennis L. Vargo

    Version of Record online : 30 OCT 2013, DOI: 10.1002/cpdd.76

  4. A Phase I cardiac safety and pharmacokinetic study of tivozanib hydrochloride in patients with advanced solid tumors

    Clinical Pharmacology in Drug Development

    Volume 3, Issue 4, July/August 2014, Pages: 284–289, Kathleen Moore, Jeffrey R. Infante, Monette M. Cotreau, Lindsey Wilson, Andrew L. Strahs, Dennis L. Vargo and Manpreet Chadha

    Version of Record online : 8 MAY 2014, DOI: 10.1002/cpdd.113

  5. The disruptor's dilemma: TiVo and the U.S. television ecosystem

    Strategic Management Journal

    Shahzad (Shaz) Ansari, Raghu Garud and Arun Kumaraswamy

    Version of Record online : 29 DEC 2015, DOI: 10.1002/smj.2442

  6. Targeted therapy for advanced renal cell carcinoma

    Intervention Review

    The Cochrane Library

    Chris Coppin, Lyly Le, Timothy J Wilt and Christian Kollmannsberger

    Published Online : 23 APR 2008, DOI: 10.1002/14651858.CD006017.pub2

  7. Discovery of New 4-Alkoxyquinazoline-Based Derivatives as Potent VEGFR2 Inhibitors

    Chemical Biology & Drug Design

    Volume 86, Issue 5, November 2015, Pages: 1323–1329, Yong Yin, Shao Sha, Yan-Ting Wang, Xun Wu, She-Feng Wang, Fang Qiao, Peng-Cheng Lv and Hai-Liang Zhu

    Version of Record online : 23 JUN 2015, DOI: 10.1111/cbdd.12596

  8. You have full text access to this OnlineOpen article
    Phase I study of tivantinib in Japanese patients with advanced hepatocellular carcinoma: Distinctive pharmacokinetic profiles from other solid tumors

    Cancer Science

    Volume 106, Issue 5, May 2015, Pages: 611–617, Takuji Okusaka, Takeshi Aramaki, Yoshitaka Inaba, Shinichiro Nakamura, Manabu Morimoto, Michihisa Moriguchi, Takashi Sato, Yuta Ikawa, Masafumi Ikeda and Junji Furuse

    Version of Record online : 7 APR 2015, DOI: 10.1111/cas.12644

  9. You have free access to this content
    Recent advances in the treatment of metastatic renal cell carcinoma

    International Journal of Urology

    Volume 20, Issue 10, October 2013, Pages: 944–955, Hideyuki Abe and Takao Kamai

    Version of Record online : 21 MAY 2013, DOI: 10.1111/iju.12187

  10. You have full text access to this OnlineOpen article
    Prognosis of Japanese patients with previously untreated metastatic renal cell carcinoma in the era of molecular-targeted therapy

    Cancer Science

    Volume 106, Issue 5, May 2015, Pages: 618–626, Nobuo Shinohara, Wataru Obara, Katsunori Tatsugami, Sei Naito, Tomomi Kamba, Masayuki Takahashi, Sachiyo Murai, Takashige Abe, Koji Oba and Seiji Naito

    Version of Record online : 19 MAR 2015, DOI: 10.1111/cas.12646

  11. You have full text access to this OnlineOpen article
    MAP3K11/GDF15 axis is a critical driver of cancer cachexia

    Journal of Cachexia, Sarcopenia and Muscle

    Lorena Lerner, Julie Tao, Qing Liu, Richard Nicoletti, Bin Feng, Brian Krieger, Elizabeth Mazsa, Zakir Siddiquee, Ruoji Wang, Lucia Huang, Luhua Shen, Jie Lin, Antonio Vigano, M. Isabel Chiu, Zhigang Weng, William Winston, Solly Weiler and Jeno Gyuris

    Version of Record online : 29 OCT 2015, DOI: 10.1002/jcsm.12077

  12. You have full text access to this Open Access content
    First-line sunitinib plus FOLFIRI in Japanese patients with unresectable/metastatic colorectal cancer: A phase II study

    Cancer Science

    Volume 103, Issue 8, August 2012, Pages: 1502–1507, Yasushi Tsuji, Taroh Satoh, Akihito Tsuji, Kei Muro, Motoki Yoshida, Tomohiro Nishina, Michitaka Nagase, Yoshito Komatsu, Takeshi Kato, Yoshinori Miyata, Naoko Mizutani, Satoshi Hashigaki, Maria Jose Lechuga and Tadamichi Denda

    Version of Record online : 14 JUN 2012, DOI: 10.1111/j.1349-7006.2012.02320.x

  13. You have free access to this content
    Targeted therapy for advanced renal cell cancer (RCC): a Cochrane systematic review of published randomised trials

    BJU International

    Volume 108, Issue 10, November 2011, Pages: 1556–1563, Chris Coppin, Christian Kollmannsberger, Lyly Le, Franz Porzsolt and Timothy J. Wilt

    Version of Record online : 27 SEP 2011, DOI: 10.1111/j.1464-410X.2011.10629.x

  14. You have free access to this content
    Invited Presentations and Oral Abstracts

    Asia-Pacific Journal of Clinical Oncology

    Volume 9, Issue S1, July 2013, Pages: 24–35,

    Version of Record online : 16 JUL 2013, DOI: 10.1111/ajco.12098_3

  15. You have free access to this content
    Current management and future perspectives of metastatic renal cell carcinoma

    International Journal of Urology

    Volume 21, Issue 9, September 2014, Pages: 847–855, Richard Lee-Ying, Renee Lester and Daniel YC Heng

    Version of Record online : 27 MAY 2014, DOI: 10.1111/iju.12502

  16. You have free access to this content
    Therapy management of cardiovascular adverse events in the context of targeted therapy for metastatic renal cell carcinoma

    International Journal of Urology

    Volume 19, Issue 9, September 2012, Pages: 796–804, Manuela Schmidinger and Jutta Bergler-Klein

    Version of Record online : 14 MAY 2012, DOI: 10.1111/j.1442-2042.2012.03033.x

  17. You have free access to this content
    Congestive heart failure risk in cancer patients treated with vascular endothelial growth factor tyrosine kinase inhibitors: a systematic review and meta-analysis of 36 clinical trials

    British Journal of Clinical Pharmacology

    Volume 78, Issue 4, October 2014, Pages: 748–762, Wei-Xiang Qi, Zan Shen, Li-Na Tang and Yang Yao

    Version of Record online : 19 SEP 2014, DOI: 10.1111/bcp.12387

  18. Comparative Reliability of Total Intracranial Volume Estimation Methods and the Influence of Atrophy in a Longitudinal Semantic Dementia Cohort

    Journal of Neuroimaging

    Volume 19, Issue 1, January 2009, Pages: 37–46, George Pengas, João M. S. Pereira, Guy B. Williams and Peter J. Nestor

    Version of Record online : 19 MAY 2008, DOI: 10.1111/j.1552-6569.2008.00246.x

  19. You have full text access to this OnlineOpen article
    Phase I / II study of brentuximab vedotin in Japanese patients with relapsed or refractory CD30-positive Hodgkin's lymphoma or systemic anaplastic large-cell lymphoma

    Cancer Science

    Volume 105, Issue 7, July 2014, Pages: 840–846, Michinori Ogura, Kensei Tobinai, Kiyohiko Hatake, Kenichi Ishizawa, Naokuni Uike, Toshiki Uchida, Tatsuya Suzuki, Tomohiro Aoki, Takashi Watanabe, Dai Maruyama, Masahiro Yokoyama, Takatoshi Takubo, Hideaki Kagehara and Takafumi Matsushima

    Version of Record online : 30 JUN 2014, DOI: 10.1111/cas.12435

  20. TIVA, TCI, and pediatrics: where are we and where are we going?

    Pediatric Anesthesia

    Volume 20, Issue 3, March 2010, Pages: 273–278, JERROLD LERMAN

    Version of Record online : 19 JAN 2010, DOI: 10.1111/j.1460-9592.2009.03238.x